tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Vistagen initiated with a Buy at Lucid Capital
PremiumThe FlyVistagen initiated with a Buy at Lucid Capital
2M ago
Vistagen Therapeutics’ Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Vistagen Therapeutics’ Earnings Call: Progress Amid Challenges
3M ago
VistaGen Therapeutics: Strong Cash Position and Promising Drug Pipeline Drive Buy Rating
Premium
Ratings
VistaGen Therapeutics: Strong Cash Position and Promising Drug Pipeline Drive Buy Rating
3M ago
Vistagen appoints Elissa Cote as Chief Corporate Development Officer
PremiumThe FlyVistagen appoints Elissa Cote as Chief Corporate Development Officer
4M ago
Vistagen Therapeutics’ Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
Vistagen Therapeutics’ Earnings Call Highlights Progress and Challenges
4M ago
Vistagen Therapeutics Reports Progress in Clinical Trials
Premium
Company Announcements
Vistagen Therapeutics Reports Progress in Clinical Trials
4M ago
Options Volatility and Implied Earnings Moves This Week, June 16 – June 20, 2025
PremiumMarket NewsOptions Volatility and Implied Earnings Moves This Week, June 16 – June 20, 2025
5M ago
VTGN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
VTGN Earnings this Week: How Will it Perform?
5M ago
VistaGen Announces Progress on PALISADE-3 Clinical Trial
Premium
Company Announcements
VistaGen Announces Progress on PALISADE-3 Clinical Trial
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100